His top achievements include the founding and formal naming of the condition, Reward Deficiency Syndrome, and having more than 500 papers written on the topic.
AUSTIN, TX, July 15, 2016 /24-7PressRelease/ -- Dr. Kenneth Blum has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Blum is an educator in physiology, pharmacology and neurogenetics whose expertise is drawn from his experience as an academician and pharmaceutical executive. Over the course of his career, he achieved noteworthy roles including Chief Scientific Advisor of Dominion Diagnostics, LLC, President, Chairman and Director of Igene, LLC, President & CEO of Synaptamine, Inc., Chief Scientific Officer of La Vita RDS, NutriGenomics, Lifegen Inc., Chief Science Advisor for Health Thru Nutrition, Malibu Beach Recovery Center, Summit Estate Recovery Center, The Shores Treatment & Recovery Center, Scientific Director of Path Foundation NYC, and Research Scientist for Southwest Research Foundation. His top achievements include the founding and formal naming of the condition, Reward Deficiency Syndrome, and having more than 500 papers written on the topic. He is also credited with discovering the first gene association for alcoholism (dopamine D2 receptor gene) and Dl-phenylalanine (an enkephalinase inhibitor that blocks alcohol craving). Additionally, Dr. Blum invented KB220 variants (Synaptamine and Thrivacin) and performed extensive research in common genetic thread for compulsive, addictive and impulsive behaviors. Along with these successes, Dr. Blum entered the field of education to share his insights and passion for pharmacology with students who share the same interest. He served as full professor, Chief of the Division of Substance Abuse in the Department of Pharmacology at University of Texas Health Sciences Center, San Antonio, retired in 1995 after 23 years of service. He was an adjunct professor at North Texas University, research professor at Wake Forest University School of Medicine. He is currently a volunteer research professor at the Florida College of Medicine. He is also volunteer Professor in the Department of Psychiatry University of Vermont, and appointed Adjunct Professor in the Department of Psychiatry, Keck Medical School, University of Southern California. Most recently he was appointed Honorary Life-Time Professor in the Department of Psychology, Institute of Psychology, Eötvös Loránd University Budapest, Hungary.
For professional excellence in recent years, Dr. Blum was selected for inclusion in Who's Who in America and Who's Who in the World. Attributing his success to his education, he holds a Ph.D. from New York Medical College, a Master of Science from New Jersey College of Medicine and a Bachelor of Science from Columbia University. A licensed pharmacist in the state of Texas, Dr. Blum shares his areas of expertise through creative and professional written works. He was the editor-in-chief of the Journal of Substance and Alcohol Misuse and Abuse (Elsevier), an editorial board member of the Journal of Physicians in Sports Medicine, and Post Graduate Medicine, and an associate editor of the Biomedical Center Research Notes and Genomic Medicine. He is also on 12 other prestigious editorial boards and has edited and written 15 books. He is the recipient a number of Life-Time Achievement awards and is the recipient of the Julius Axelrod (Nobel Laureate) Distinguished Speaker Award. He is also the founding President of United Scientific Group (USG), Editor-in-Chief of the Journal of Reward Deficiency Syndrome & Addiction Science and Co-editor-in-Chief of Neuroimaging in Psychiatry and Neurology. He has chaired two Gordon Research conferences on alcoholism and Founder Chair of Psychiatric Genetics. Looking ahead, Dr. Blum intends to continue working in the field of Psychiatric Genetics and development of Genetic Addiction Risk Score (GARS) and Addiction Medicine.
About Marquis Who's Who:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America, Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis now publishes many Who's Who titles, including Who's Who in America, Who's Who in the World, Who's Who in American Law, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, and Who's Who in Asia. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.
# # #